Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years

NCT00825162

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • The Canberra Hospital Garran, Australian Capital Territory, Australia
  • Sydney Children's Clinical Trials Centre Randwick, New South Wales, Australia
  • Children's Hospital at Westmead Westmead, New South Wales, Australia
  • Royal Children's Hospital Herston, Queensland, Australia
View Trial Details
Completed

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age

NCT02545543

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • Site 296 Huntsville, Alabama, United States
  • Site 401 Madera, California, United States
  • Site 397 Ontario, California, United States
  • Site 392 Redding, California, United States
View all 32 locations
View Trial Details
Completed

Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

NCT02612922

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Influence Study Site Hot Springs, Arkansas, United States
  • Influence Study Site Anaheim, California, United States
  • Influence Study Site Fresno, California, United States
  • Influence Study Site Lomita, California, United States
View all 28 locations
View Trial Details
Completed

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

NCT02218697

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +10 more
Locations
  • GSK Investigational Site Ghent, Belgium
  • GSK Investigational Site Angers, France
  • GSK Investigational Site Laval, France
  • GSK Investigational Site Nantes, France
View Trial Details
Completed

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

NCT01517191

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • Vancouver General Vancouver, British Columbia, Canada
  • The Moncton Hospital Moncton, New Brunswick, Canada
  • Saint John Regional Hospital Saint John, New Brunswick, Canada
  • QEII Health Science Centre Halifax, Nova Scotia, Canada
View all 14 locations
View Trial Details

Related conditions